BRIEF-IMF Bentham updates on settlement of an Australian matter it funded
* refers to its previous announcement on 22 July 2016 concerning conditional settlement of an australian matter it has funded.
Dec 29 Imprimis Pharmaceuticals Inc :
* Imprimis Pharmaceuticals-amendment allowed to exchange $3 million principal balance convertible note dated Jan 22, 2016 for $3 million term loan-sec filing
* Imprimis Pharmaceuticals- on Dec 27 co entered into third amendment to loan and security agreement dated May 11, 2015-sec filing Source text - bit.ly/2hza1G5 Further company coverage: